Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q64869347
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241121000338.0 |
008
|
|
|
241121nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q64869347
|
024
|
|
|
‡a
0000-0003-2167-9393
‡2
orcid
|
035
|
|
|
‡a
(OCoLC)Q64869347
|
100
|
0 |
|
‡a
Jin Kyun Park
‡c
researcher
‡9
en
|
400
|
0 |
|
‡a
Jin Kyun Park
‡c
wetenschapper
‡9
nl
|
400
|
0 |
|
‡a
Jin Kyun Park
‡c
investigador
‡9
es
|
670
|
|
|
‡a
Author's A decision model for the watch-and-wait strategy in systemic sclerosis-associated interstitial lung disease
|
670
|
|
|
‡a
Author's Advancing the Development of Patient-reported Outcomes for Adult Myositis at OMERACT 2016: An International Delphi Study
|
670
|
|
|
‡a
Author's Altered lipoproteins in patients with systemic lupus erythematosus are associated with augmented oxidative stress: a potential role in atherosclerosis.
|
670
|
|
|
‡a
Author's Association between fever pattern and clinical manifestations of adult-onset Still's disease: unbiased analysis using hierarchical clustering
|
670
|
|
|
‡a
Author's Association of Acroosteolysis With Enhanced Osteoclastogenesis and Higher Blood Levels of Vascular Endothelial Growth Factor in Systemic Sclerosis
|
670
|
|
|
‡a
Author's ASXL1 is a molecular predictor in idiopathic cytopenia of undetermined significance
|
670
|
|
|
‡a
Author's Baseline peripheral blood neutrophil-to-lymphocyte ratio could predict survival in patients with adult polymyositis and dermatomyositis: A retrospective observational study.
|
670
|
|
|
‡a
Author's Cathepsin K Contributes to Cavitation and Collagen Turnover in Pulmonary Tuberculosis
|
670
|
|
|
‡a
Author's Certain Autoimmune Manifestations Are Associated With Distinctive Karyotypes and Outcomes in Patients With Myelodysplastic Syndrome: A Retrospective Cohort Study
|
670
|
|
|
‡a
Author's Changes in serum uric acid levels after allogeneic hematologic stem cell transplantation: A retrospective cohort study.
|
670
|
|
|
‡a
Author's Circulating exosomes from patients with systemic lupus erythematosus induce an proinflammatory immune response.
|
670
|
|
|
‡a
Author's Citrullination of myofilament proteins in heart failure
|
670
|
|
|
‡a
Author's Clinical characteristics associated with occurrence and poor prognosis of interstitial lung disease in rheumatoid arthritis.
|
670
|
|
|
‡a
Author's Comparison of cancer incidence among patients with rheumatic disease: a retrospective cohort study.
|
670
|
|
|
‡a
Author's Comparison of tuberculosis incidence in ankylosing spondylitis and rheumatoid arthritis during tumor necrosis factor inhibitor treatment in an intermediate burden area
|
670
|
|
|
‡a
Author's CXCL10/CXCR3 axis is associated with disease activity and the development of mucocutaneous lesions in patients with Behçet's disease.
|
670
|
|
|
‡a
Author's Cytokine signaling-1 suppressor is inducible by IL-1beta and inhibits the catabolic effects of IL-1beta in chondrocytes: its implication in the paradoxical joint-protective role of IL-1beta
|
670
|
|
|
‡a
Author's Decreased tumour necrosis factor-α production by monocytes of granulomatosis with polyangiitis.
|
670
|
|
|
‡a
Author's Dermatomyositis as the initial presentation of a large anaplastic T-cell lymphoma
|
670
|
|
|
‡a
Author's Diffuse papules and skin tightening.
|
670
|
|
|
‡a
Author's Effect of methotrexate discontinuation on efficacy of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial
|
670
|
|
|
‡a
Author's Efficacy and Tolerability of GCSB-5 for Hand Osteoarthritis: A Randomized, Controlled Trial.
|
670
|
|
|
‡a
Author's Elderly Patients Exhibit Stronger Inflammatory Responses during Gout Attacks
|
670
|
|
|
‡a
Author's Elevated Erythrocyte Sedimentation Rate Is Predictive of Interstitial Lung Disease and Mortality in Dermatomyositis: a Korean Retrospective Cohort Study.
|
670
|
|
|
‡a
Author's Expression of cathepsin K and tartrate-resistant acid phosphatase is not confined to osteoclasts but is a general feature of multinucleated giant cells: systematic analysis.
|
670
|
|
|
‡a
Author's Fever and Debilitating Myalgia
|
670
|
|
|
‡a
Author's Impact of temporary methotrexate discontinuation for 2 weeks on immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial.
|
670
|
|
|
‡a
Author's Increased generation of TRAP expressing multinucleated giant cells in patients with granulomatosis with polyangiitis.
|
670
|
|
|
‡a
Author's Interaction between B-cell activation factor and methotrexate impacts immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis
|
670
|
|
|
‡a
Author's Myocardial citrullination in rheumatoid arthritis: a correlative histopathologic study.
|
670
|
|
|
‡a
Author's Nonthrombotic proliferative vasculopathy associated with antiphospholipid antibodies: A case report and literature review
|
670
|
|
|
‡a
Author's Occult erosions in Jaccoud arthropathy
|
670
|
|
|
‡a
Author's OMERACT 2018 Modified Patient-reported Outcome Domain Core Set in the Life Impact Area for Adult Idiopathic Inflammatory Myopathies
|
670
|
|
|
‡a
Author's Optimal time between the last methotrexate administration and seasonal influenza vaccination in rheumatoid arthritis: post hoc analysis of a randomised clinical trial
|
670
|
|
|
‡a
Author's Osteoclast-like multinucleated giant cells in sinonasal inflammation of granulomatosis with polyangiitis
|
670
|
|
|
‡a
Author's Osteoclast-like multinucleated giant cells in sinonasal inflammation of granulomatosis with polyangiitis (Wegener's granulomatosis).
|
670
|
|
|
‡a
Author's Patients with Rheumatoid Arthritis Show Altered Lipoprotein Profiles with Dysfunctional High-Density Lipoproteins that Can Exacerbate Inflammatory and Atherogenic Process
|
670
|
|
|
‡a
Author's Perceptions of Patients, Caregivers, and Healthcare Providers of Idiopathic Inflammatory Myopathies: An International OMERACT Study
|
670
|
|
|
‡a
Author's Performance of the 2015 American College of Rheumatology/European League against Rheumatism Classification Criteria for Gout in Korean Patients with Acute Arthritis
|
670
|
|
|
‡a
Author's Proteomic biomarkers in mid-trimester amniotic fluid associated with adverse pregnancy outcomes in patients with systemic lupus erythematosus
|
670
|
|
|
‡a
Author's Pulmonary impairment, not muscle injury, is associated with elevated ESR in the idiopathic inflammatory myopathies.
|
670
|
|
|
‡a
Author's Raynaud's phenomenon and anti-nuclear antibody are associated with pulmonary function decline in patients with dermatomyositis and polymyositis
|
670
|
|
|
‡a
Author's Recurrent Kawasaki disease with strawberry tongue and skin desquamation in a young adult.
|
670
|
|
|
‡a
Author's Rheumatoid arthritis subgroup with type I interferon signature: comment on the article by Thurlings et al
|
670
|
|
|
‡a
Author's Serum 25-Hydroxyvitamin D3 and BAFF Levels Are Associated with Disease Activity in Primary Sjogren's Syndrome.
|
670
|
|
|
‡a
Author's Serum levels of IgG antibodies against alpha-enolase are increased in patients with Behçet's disease and are associated with the severity of oral ulcer, erythrocyte sedimentation rates, and C-reactive protein
|
670
|
|
|
‡a
Author's Subscapular bursitis as a rare manifestation of dermatomyositis: a case report.
|
670
|
|
|
‡a
Author's Survival benefit associated with early cyclosporine treatment for dermatomyositis-associated interstitial lung disease.
|
670
|
|
|
‡a
Author's Survival rates of cancer patients with and without rheumatic disease: a retrospective cohort analysis
|
670
|
|
|
‡a
Author's T helper 1/T helper 2 balance and HMG-CoA reductase inhibitors in acute coronary syndrome: statins as immunomodulatory agents?
|
670
|
|
|
‡a
Author's The Practice Guideline for Vaccinating Korean Patients with Autoimmune Inflammatory Rheumatic Disease
|
670
|
|
|
‡a
Author's Therapeutic effect of a novel histone deacetylase 6 inhibitor, CKD-L, on collagen-induced arthritis in vivo and regulatory T cells in rheumatoid arthritis in vitro.
|
670
|
|
|
‡a
Author's Tracheobronchial Cobblestone in Relapsing Polychondritis
|
909
|
|
|
‡a
(orcid) 0000000321679393
‡9
1
|
919
|
|
|
‡a
cathepsinkcontributestocavitationandcollagenturnoverinpulmonarytuberculosis
‡A
Cathepsin K Contributes to Cavitation and Collagen Turnover in Pulmonary Tuberculosis
‡9
1
|
919
|
|
|
‡a
increasedgenerationoftrapexpressingmultinucleatedgiantcellsinpatientswithgranulomatosiswithpolyangiitis
‡A
Increased generation of TRAP expressing multinucleated giant cells in patients with granulomatosis with polyangiitis.
‡9
1
|
919
|
|
|
‡a
interactionbetweenbcellactivationfactorandmethotrexateimpactsimmunogenicityofseasonalinfluenzavaccinationinpatientswithrheumatoidarthritis
‡A
Interaction between B-cell activation factor and methotrexate impacts immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis
‡9
1
|
919
|
|
|
‡a
myocardialcitrullinationinrheumatoidarthritisacorrelativehistopathologicstudy
‡A
Myocardial citrullination in rheumatoid arthritis: a correlative histopathologic study.
‡9
1
|
919
|
|
|
‡a
nonthromboticproliferativevasculopathyassociatedwithantiphospholipidantibodiesacasereportandliteraturereview
‡A
Nonthrombotic proliferative vasculopathy associated with antiphospholipid antibodies: A case report and literature review
‡9
1
|
919
|
|
|
‡a
occulterosionsinjaccoudarthropathy
‡A
Occult erosions in Jaccoud arthropathy
‡9
1
|
919
|
|
|
‡a
omeract2018modifiedpatientreportedoutcomedomaincoresetinthelifeimpactareaforadultidiopathicinflammatorymyopathies
‡A
OMERACT 2018 Modified Patient-reported Outcome Domain Core Set in the Life Impact Area for Adult Idiopathic Inflammatory Myopathies
‡9
1
|
919
|
|
|
‡a
optimaltimebetweenthelastmethotrexateadministrationandseasonalinfluenzavaccinationinrheumatoidarthritisposthocanalysisofarandomisedclinicaltrial
‡A
Optimal time between the last methotrexate administration and seasonal influenza vaccination in rheumatoid arthritis: post hoc analysis of a randomised clinical trial
‡9
1
|
919
|
|
|
‡a
osteoclastlikemultinucleatedgiantcellsinsinonasalinflammationofgranulomatosiswithpolyangiitis
‡A
Osteoclast-like multinucleated giant cells in sinonasal inflammation of granulomatosis with polyangiitis
‡9
1
|
919
|
|
|
‡a
osteoclastlikemultinucleatedgiantcellsinsinonasalinflammationofgranulomatosiswithpolyangiitiswegenersgranulomatosis
‡A
Osteoclast-like multinucleated giant cells in sinonasal inflammation of granulomatosis with polyangiitis (Wegener's granulomatosis).
‡9
1
|
919
|
|
|
‡a
patientswithrheumatoidarthritisshowalteredlipoproteinprofileswithdysfunctionalhighdensitylipoproteinsthatcanexacerbateinflammatoryandatherogenicprocess
‡A
Patients with Rheumatoid Arthritis Show Altered Lipoprotein Profiles with Dysfunctional High-Density Lipoproteins that Can Exacerbate Inflammatory and Atherogenic Process
‡9
1
|
919
|
|
|
‡a
perceptionsofpatientscaregiversandhealthcareprovidersofidiopathicinflammatorymyopathiesaninternationalomeractstudy
‡A
Perceptions of Patients, Caregivers, and Healthcare Providers of Idiopathic Inflammatory Myopathies: An International OMERACT Study
‡9
1
|
919
|
|
|
‡a
performanceofthe2015americancollegeofrheumatologyeuropeanleagueagainstrheumatismclassificationcriteriaforgoutinkoreanpatientswithacutearthritis
‡A
Performance of the 2015 American College of Rheumatology/European League against Rheumatism Classification Criteria for Gout in Korean Patients with Acute Arthritis
‡9
1
|
919
|
|
|
‡a
proteomicbiomarkersinmidtrimesteramnioticfluidassociatedwithadversepregnancyoutcomesinpatientswithsystemiclupuserythematosus
‡A
Proteomic biomarkers in mid-trimester amniotic fluid associated with adverse pregnancy outcomes in patients with systemic lupus erythematosus
‡9
1
|
919
|
|
|
‡a
pulmonaryimpairmentnotmuscleinjuryisassociatedwithelevatedesrintheidiopathicinflammatorymyopathies
‡A
Pulmonary impairment, not muscle injury, is associated with elevated ESR in the idiopathic inflammatory myopathies.
‡9
1
|
919
|
|
|
‡a
raynaudsphenomenonandantinuclearantibodyareassociatedwithpulmonaryfunctiondeclineinpatientswithdermatomyositisandpolymyositis
‡A
Raynaud's phenomenon and anti-nuclear antibody are associated with pulmonary function decline in patients with dermatomyositis and polymyositis
‡9
1
|
919
|
|
|
‡a
recurrentkawasakidiseasewithstrawberrytongueandskindesquamationinayoungadult
‡A
Recurrent Kawasaki disease with strawberry tongue and skin desquamation in a young adult.
‡9
1
|
919
|
|
|
‡a
rheumatoidarthritissubgroupwithtype1interferonsignaturecommentonthearticlebythurlingsetal
‡A
Rheumatoid arthritis subgroup with type I interferon signature: comment on the article by Thurlings et al
‡9
1
|
919
|
|
|
‡a
serum25hydroxyvitamind3andbafflevelsareassociatedwithdiseaseactivityinprimarysjogrenssyndrome
‡A
Serum 25-Hydroxyvitamin D3 and BAFF Levels Are Associated with Disease Activity in Primary Sjogren's Syndrome.
‡9
1
|
919
|
|
|
‡a
serumlevelsofiggantibodiesagainstalphaenolaseareincreasedinpatientswithbehcetsdiseaseandareassociatedwiththeseverityoforalulcererythrocytesedimentationratesand100reactiveprotein
‡A
Serum levels of IgG antibodies against alpha-enolase are increased in patients with Behçet's disease and are associated with the severity of oral ulcer, erythrocyte sedimentation rates, and C-reactive protein
‡9
1
|
919
|
|
|
‡a
subscapularbursitisasararemanifestationofdermatomyositisacasereport
‡A
Subscapular bursitis as a rare manifestation of dermatomyositis: a case report.
‡9
1
|
919
|
|
|
‡a
survivalbenefitassociatedwithearlycyclosporinetreatmentfordermatomyositisassociatedinterstitiallungdisease
‡A
Survival benefit associated with early cyclosporine treatment for dermatomyositis-associated interstitial lung disease.
‡9
1
|
919
|
|
|
‡a
survivalratesofcancerpatientswithandwithoutrheumaticdiseasearetrospectivecohortanalysis
‡A
Survival rates of cancer patients with and without rheumatic disease: a retrospective cohort analysis
‡9
1
|
919
|
|
|
‡a
thelper1thelper2balanceandhmgcoareductaseinhibitorsinacutecoronarysyndromestatinsasimmunomodulatoryagents
‡A
T helper 1/T helper 2 balance and HMG-CoA reductase inhibitors in acute coronary syndrome: statins as immunomodulatory agents?
‡9
1
|
919
|
|
|
‡a
practiceguidelineforvaccinatingkoreanpatientswithautoimmuneinflammatoryrheumaticdisease
‡A
The Practice Guideline for Vaccinating Korean Patients with Autoimmune Inflammatory Rheumatic Disease
‡9
1
|
919
|
|
|
‡a
therapeuticeffectofanovelhistonedeacetylase6inhibitorckd50oncollageninducedarthritisinvivoandregulatorytcellsinrheumatoidarthritisinvitro
‡A
Therapeutic effect of a novel histone deacetylase 6 inhibitor, CKD-L, on collagen-induced arthritis in vivo and regulatory T cells in rheumatoid arthritis in vitro.
‡9
1
|
919
|
|
|
‡a
tracheobronchialcobblestoneinrelapsingpolychondritis
‡A
Tracheobronchial Cobblestone in Relapsing Polychondritis
‡9
1
|
919
|
|
|
‡a
impactoftemporarymethotrexatediscontinuationfor2weeksonimmunogenicityofseasonalinfluenzavaccinationinpatientswithrheumatoidarthritisarandomisedclinicaltrial
‡A
Impact of temporary methotrexate discontinuation for 2 weeks on immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial.
‡9
1
|
919
|
|
|
‡a
feveranddebilitatingmyalgia
‡A
Fever and Debilitating Myalgia
‡9
1
|
919
|
|
|
‡a
expressionofcathepsinkandtartrateresistantacidphosphataseisnotconfinedtoosteoclastsbutisageneralfeatureofmultinucleatedgiantcellssystematicanalysis
‡A
Expression of cathepsin K and tartrate-resistant acid phosphatase is not confined to osteoclasts but is a general feature of multinucleated giant cells: systematic analysis.
‡9
1
|
919
|
|
|
‡a
elevatederythrocytesedimentationrateispredictiveofinterstitiallungdiseaseandmortalityindermatomyositisakoreanretrospectivecohortstudy
‡A
Elevated Erythrocyte Sedimentation Rate Is Predictive of Interstitial Lung Disease and Mortality in Dermatomyositis: a Korean Retrospective Cohort Study.
‡9
1
|
919
|
|
|
‡a
elderlypatientsexhibitstrongerinflammatoryresponsesduringgoutattacks
‡A
Elderly Patients Exhibit Stronger Inflammatory Responses during Gout Attacks
‡9
1
|
919
|
|
|
‡a
efficacyandtolerabilityofgcsb5forhandosteoarthritisarandomizedcontrolledtrial
‡A
Efficacy and Tolerability of GCSB-5 for Hand Osteoarthritis: A Randomized, Controlled Trial.
‡9
1
|
919
|
|
|
‡a
effectofmethotrexatediscontinuationonefficacyofseasonalinfluenzavaccinationinpatientswithrheumatoidarthritisarandomisedclinicaltrial
‡A
Effect of methotrexate discontinuation on efficacy of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial
‡9
1
|
919
|
|
|
‡a
diffusepapulesandskintightening
‡A
Diffuse papules and skin tightening.
‡9
1
|
919
|
|
|
‡a
dermatomyositisastheinitialpresentationofalargeanaplastictcelllymphoma
‡A
Dermatomyositis as the initial presentation of a large anaplastic T-cell lymphoma
‡9
1
|
919
|
|
|
‡a
certainautoimmunemanifestationsareassociatedwithdistinctivekaryotypesandoutcomesinpatientswithmyelodysplasticsyndromearetrospectivecohortstudy
‡A
Certain Autoimmune Manifestations Are Associated With Distinctive Karyotypes and Outcomes in Patients With Myelodysplastic Syndrome: A Retrospective Cohort Study
‡9
1
|
919
|
|
|
‡a
decreasedtumournecrosisfactorαproductionbymonocytesofgranulomatosiswithpolyangiitis
‡A
Decreased tumour necrosis factor-α production by monocytes of granulomatosis with polyangiitis.
‡9
1
|
919
|
|
|
‡a
cytokinesignaling1suppressorisinduciblebyil1betaandinhibitsthecataboliceffectsofil1betainchondrocytesitsimplicationintheparadoxicaljointprotectiveroleofil1beta
‡A
Cytokine signaling-1 suppressor is inducible by IL-1beta and inhibits the catabolic effects of IL-1beta in chondrocytes: its implication in the paradoxical joint-protective role of IL-1beta
‡9
1
|
919
|
|
|
‡a
cxcl10cxcr3axisisassociatedwithdiseaseactivityandthedevelopmentofmucocutaneouslesionsinpatientswithbehcetsdisease
‡A
CXCL10/CXCR3 axis is associated with disease activity and the development of mucocutaneous lesions in patients with Behçet's disease.
‡9
1
|
919
|
|
|
‡a
comparisonoftuberculosisincidenceinankylosingspondylitisandrheumatoidarthritisduringtumornecrosisfactorinhibitortreatmentinanintermediateburdenarea
‡A
Comparison of tuberculosis incidence in ankylosing spondylitis and rheumatoid arthritis during tumor necrosis factor inhibitor treatment in an intermediate burden area
‡9
1
|
919
|
|
|
‡a
comparisonofcancerincidenceamongpatientswithrheumaticdiseasearetrospectivecohortstudy
‡A
Comparison of cancer incidence among patients with rheumatic disease: a retrospective cohort study.
‡9
1
|
919
|
|
|
‡a
decisionmodelforthewatchandwaitstrategyinsystemicsclerosisassociatedinterstitiallungdisease
‡A
A decision model for the watch-and-wait strategy in systemic sclerosis-associated interstitial lung disease
‡9
1
|
919
|
|
|
‡a
advancingthedevelopmentofpatientreportedoutcomesforadultmyositisatomeract2016aninternationaldelphistudy
‡A
Advancing the Development of Patient-reported Outcomes for Adult Myositis at OMERACT 2016: An International Delphi Study
‡9
1
|
919
|
|
|
‡a
alteredlipoproteinsinpatientswithsystemiclupuserythematosusareassociatedwithaugmentedoxidativestressapotentialroleinatherosclerosis
‡A
Altered lipoproteins in patients with systemic lupus erythematosus are associated with augmented oxidative stress: a potential role in atherosclerosis.
‡9
1
|
919
|
|
|
‡a
associationbetweenfeverpatternandclinicalmanifestationsofadultonsetstillsdiseaseunbiasedanalysisusinghierarchicalclustering
‡A
Association between fever pattern and clinical manifestations of adult-onset Still's disease: unbiased analysis using hierarchical clustering
‡9
1
|
919
|
|
|
‡a
clinicalcharacteristicsassociatedwithoccurrenceandpoorprognosisofinterstitiallungdiseaseinrheumatoidarthritis
‡A
Clinical characteristics associated with occurrence and poor prognosis of interstitial lung disease in rheumatoid arthritis.
‡9
1
|
919
|
|
|
‡a
associationofacroosteolysiswithenhancedosteoclastogenesisandhigherbloodlevelsofvascularendothelialgrowthfactorinsystemicsclerosis
‡A
Association of Acroosteolysis With Enhanced Osteoclastogenesis and Higher Blood Levels of Vascular Endothelial Growth Factor in Systemic Sclerosis
‡9
1
|
919
|
|
|
‡a
asxl1isamolecularpredictorinidiopathiccytopeniaofundeterminedsignificance
‡A
ASXL1 is a molecular predictor in idiopathic cytopenia of undetermined significance
‡9
1
|
919
|
|
|
‡a
baselineperipheralbloodneutrophiltolymphocyteratiocouldpredictsurvivalinpatientswithadultpolymyositisanddermatomyositisaretrospectiveobservationalstudy
‡A
Baseline peripheral blood neutrophil-to-lymphocyte ratio could predict survival in patients with adult polymyositis and dermatomyositis: A retrospective observational study.
‡9
1
|
919
|
|
|
‡a
citrullinationofmyofilamentproteinsinheartfailure
‡A
Citrullination of myofilament proteins in heart failure
‡9
1
|
919
|
|
|
‡a
circulatingexosomesfrompatientswithsystemiclupuserythematosusinduceanproinflammatoryimmuneresponse
‡A
Circulating exosomes from patients with systemic lupus erythematosus induce an proinflammatory immune response.
‡9
1
|
919
|
|
|
‡a
changesinserumuricacidlevelsafterallogeneichematologicstemcelltransplantationaretrospectivecohortstudy
‡A
Changes in serum uric acid levels after allogeneic hematologic stem cell transplantation: A retrospective cohort study.
‡9
1
|
996
|
|
|
‡2
ISNI|0000000491569509
|
996
|
|
|
‡2
ISNI|000000047235617X
|
996
|
|
|
‡2
J9U|987007577262805171
|
996
|
|
|
‡2
NUKAT|n 2013125667
|
996
|
|
|
‡2
ISNI|0000000468546253
|
996
|
|
|
‡2
ISNI|0000000472574994
|
996
|
|
|
‡2
DNB|141174889
|
996
|
|
|
‡2
ISNI|000000051479606X
|
996
|
|
|
‡2
LC|nr2002018375
|
996
|
|
|
‡2
ISNI|0000000493203519
|
996
|
|
|
‡2
ISNI|0000000493256098
|
996
|
|
|
‡2
ISNI|0000000493142189
|
996
|
|
|
‡2
ISNI|0000000504174056
|
996
|
|
|
‡2
ISNI|0000000464406966
|
996
|
|
|
‡2
ISNI|0000000467665322
|
996
|
|
|
‡2
ISNI|000000049391832X
|
996
|
|
|
‡2
ISNI|0000000512293020
|
996
|
|
|
‡2
LC|n 2015186918
|
996
|
|
|
‡2
ISNI|0000000505565040
|
996
|
|
|
‡2
ISNI|0000000473576043
|
996
|
|
|
‡2
ISNI|0000000479083071
|
996
|
|
|
‡2
ISNI|0000000491381610
|
996
|
|
|
‡2
LC|no2008074745
|
996
|
|
|
‡2
ISNI|0000000119135878
|
996
|
|
|
‡2
ISNI|0000000493214496
|
996
|
|
|
‡2
ISNI|0000000467805161
|
996
|
|
|
‡2
ISNI|0000000480097032
|
996
|
|
|
‡2
ISNI|0000000493215229
|
996
|
|
|
‡2
ISNI|000000046484531X
|
996
|
|
|
‡2
ISNI|0000000492034231
|
996
|
|
|
‡2
ISNI|0000000463568568
|
996
|
|
|
‡2
ISNI|0000000474985017
|
996
|
|
|
‡2
ISNI|0000000505163682
|
996
|
|
|
‡2
BNF|16016163
|
996
|
|
|
‡2
ISNI|0000000512529857
|
996
|
|
|
‡2
ISNI|0000000465125138
|
996
|
|
|
‡2
ISNI|0000000491633697
|
996
|
|
|
‡2
ISNI|0000000514738978
|
996
|
|
|
‡2
ISNI|0000000512312869
|
996
|
|
|
‡2
ISNI|0000000464283257
|
996
|
|
|
‡2
ISNI|0000000473884628
|
996
|
|
|
‡2
ISNI|0000000474720684
|
996
|
|
|
‡2
SUDOC|183417879
|
996
|
|
|
‡2
ISNI|0000000514468787
|
996
|
|
|
‡2
ISNI|0000000513177128
|
996
|
|
|
‡2
ISNI|0000000477655750
|
996
|
|
|
‡2
ISNI|0000000492210987
|
996
|
|
|
‡2
ISNI|0000000467900265
|
996
|
|
|
‡2
ISNI|0000000475841859
|
996
|
|
|
‡2
ISNI|0000000468028712
|
996
|
|
|
‡2
ISNI|0000000461106976
|
996
|
|
|
‡2
DNB|133900878
|
996
|
|
|
‡2
DNB|115208383X
|
996
|
|
|
‡2
J9U|987007405124705171
|
996
|
|
|
‡2
ISNI|0000000463442105
|
996
|
|
|
‡2
ISNI|0000000474045631
|
996
|
|
|
‡2
ISNI|000000047875809X
|
996
|
|
|
‡2
ISNI|0000000492191114
|
996
|
|
|
‡2
ISNI|0000000475028331
|
996
|
|
|
‡2
ISNI|0000000492490317
|
996
|
|
|
‡2
JPG|500042384
|
996
|
|
|
‡2
ISNI|0000000510933004
|
996
|
|
|
‡2
ISNI|0000000474002412
|
996
|
|
|
‡2
ISNI|0000000480110866
|
996
|
|
|
‡2
DNB|1109763743
|
996
|
|
|
‡2
NSK|000280757
|
996
|
|
|
‡2
ISNI|0000000484962046
|
996
|
|
|
‡2
ISNI|0000000493256071
|
996
|
|
|
‡2
ISNI|0000000474049878
|
996
|
|
|
‡2
ISNI|0000000036253844
|
996
|
|
|
‡2
ISNI|0000000505415114
|
996
|
|
|
‡2
ISNI|0000000492489834
|
996
|
|
|
‡2
ISNI|000000046792497X
|
996
|
|
|
‡2
ISNI|0000000049645388
|
996
|
|
|
‡2
NTA|243320442
|
996
|
|
|
‡2
ISNI|0000000036467412
|
996
|
|
|
‡2
ISNI|0000000475046847
|
996
|
|
|
‡2
SUDOC|081257392
|
996
|
|
|
‡2
BIBSYS|5095909
|
996
|
|
|
‡2
ISNI|0000000477157831
|
996
|
|
|
‡2
ISNI|0000000492489922
|
996
|
|
|
‡2
LC|n 2013057913
|
996
|
|
|
‡2
ISNI|0000000473920369
|
996
|
|
|
‡2
ISNI|0000000473742689
|
996
|
|
|
‡2
ISNI|0000000505416117
|
996
|
|
|
‡2
ISNI|0000000492081978
|
996
|
|
|
‡2
ISNI|000000047932420X
|
996
|
|
|
‡2
ISNI|000000047896503X
|
996
|
|
|
‡2
ISNI|000000046330938X
|
996
|
|
|
‡2
ISNI|0000000468703941
|
996
|
|
|
‡2
ISNI|0000000461106896
|
996
|
|
|
‡2
DNB|1200031520
|
996
|
|
|
‡2
ISNI|0000000468671724
|
996
|
|
|
‡2
ISNI|0000000504634649
|
996
|
|
|
‡2
ISNI|0000000477154366
|
996
|
|
|
‡2
ISNI|0000000492382404
|
996
|
|
|
‡2
ISNI|0000000479039863
|
996
|
|
|
‡2
ISNI|0000000480097251
|
996
|
|
|
‡2
ISNI|0000000468046910
|
996
|
|
|
‡2
ISNI|0000000512673955
|
996
|
|
|
‡2
ISNI|0000000505524353
|
996
|
|
|
‡2
ISNI|0000000460985905
|
996
|
|
|
‡2
ISNI|0000000476384776
|
996
|
|
|
‡2
PTBNP|137413
|
996
|
|
|
‡2
ISNI|0000000501816113
|
996
|
|
|
‡2
ISNI|000000046611940X
|
996
|
|
|
‡2
NLA|000035267324
|
996
|
|
|
‡2
ISNI|0000000503370733
|
996
|
|
|
‡2
ISNI|000000004770126X
|
996
|
|
|
‡2
ISNI|0000000468139834
|
996
|
|
|
‡2
ISNI|0000000463257823
|
996
|
|
|
‡2
ISNI|0000000492203883
|
996
|
|
|
‡2
LC|n 91001932
|
996
|
|
|
‡2
ISNI|0000000464937134
|
996
|
|
|
‡2
ISNI|0000000493630414
|
996
|
|
|
‡2
ISNI|0000000493283424
|
996
|
|
|
‡2
ISNI|0000000493137945
|
996
|
|
|
‡2
ISNI|0000000479082714
|
996
|
|
|
‡2
ISNI|0000000468026792
|
996
|
|
|
‡2
LC|no2010003584
|
996
|
|
|
‡2
ISNI|0000000483952196
|
996
|
|
|
‡2
ISNI|0000000505185574
|
996
|
|
|
‡2
ISNI|0000000494051422
|
996
|
|
|
‡2
ISNI|0000000505065548
|
996
|
|
|
‡2
ISNI|0000000073715999
|
996
|
|
|
‡2
ISNI|0000000492344694
|
996
|
|
|
‡2
NUKAT|n 2011110509
|
996
|
|
|
‡2
ISNI|0000000465028397
|
996
|
|
|
‡2
ISNI|0000000504783871
|
996
|
|
|
‡2
PLWABN|9810678060205606
|
996
|
|
|
‡2
ISNI|0000000493918063
|
996
|
|
|
‡2
PLWABN|9814249616805606
|
996
|
|
|
‡2
ISNI|0000000042150278
|
996
|
|
|
‡2
ISNI|0000000505310291
|
996
|
|
|
‡2
DE633|pe41001779
|
996
|
|
|
‡2
ISNI|0000000511426493
|
996
|
|
|
‡2
ISNI|0000000491381629
|
996
|
|
|
‡2
ISNI|0000000493924375
|
996
|
|
|
‡2
ISNI|0000000505630236
|
996
|
|
|
‡2
ISNI|0000000512727677
|
996
|
|
|
‡2
ISNI|0000000460706048
|
996
|
|
|
‡2
ISNI|0000000480230008
|
996
|
|
|
‡2
ISNI|0000000463394529
|
996
|
|
|
‡2
ISNI|0000000473745046
|
996
|
|
|
‡2
ISNI|0000000494056311
|
996
|
|
|
‡2
ISNI|0000000492063032
|
996
|
|
|
‡2
ISNI|000000049405026X
|
996
|
|
|
‡2
ISNI|0000000513546544
|
996
|
|
|
‡2
BNE|XX4834911
|
996
|
|
|
‡2
ISNI|0000000463612960
|
996
|
|
|
‡2
ISNI|0000000459871054
|
996
|
|
|
‡2
LC|n 81077799
|
996
|
|
|
‡2
ISNI|0000000474359593
|
996
|
|
|
‡2
ISNI|000000046458261X
|
996
|
|
|
‡2
ISNI|000000046485833X
|
996
|
|
|
‡2
ISNI|0000000491588339
|
996
|
|
|
‡2
ISNI|000000045987102X
|
996
|
|
|
‡2
ISNI|0000000461106925
|
996
|
|
|
‡2
BIBSYS|90394807
|
996
|
|
|
‡2
LC|n 84108488
|
996
|
|
|
‡2
ISNI|0000000493216395
|
996
|
|
|
‡2
ISNI|0000000480229648
|
996
|
|
|
‡2
SUDOC|198741723
|
996
|
|
|
‡2
ISNI|0000000467636732
|
996
|
|
|
‡2
ISNI|0000000479744271
|
996
|
|
|
‡2
ISNI|0000000479083493
|
996
|
|
|
‡2
ISNI|0000000477764500
|
996
|
|
|
‡2
ISNI|0000000505297963
|
996
|
|
|
‡2
ISNI|0000000493256039
|
996
|
|
|
‡2
ISNI|000000046770351X
|
996
|
|
|
‡2
ISNI|000000046484013X
|
996
|
|
|
‡2
ISNI|0000000505756656
|
996
|
|
|
‡2
ISNI|0000000464800808
|
996
|
|
|
‡2
ISNI|0000000483484783
|
996
|
|
|
‡2
ISNI|0000000491588144
|
996
|
|
|
‡2
ISNI|0000000464418625
|
996
|
|
|
‡2
ISNI|000000047790215X
|
996
|
|
|
‡2
ISNI|0000000464714782
|
996
|
|
|
‡2
ISNI|0000000479267540
|
996
|
|
|
‡2
ISNI|0000000477648841
|
996
|
|
|
‡2
ISNI|0000000491744506
|
996
|
|
|
‡2
ISNI|0000000480197463
|
996
|
|
|
‡2
ISNI|0000000503975580
|
996
|
|
|
‡2
ISNI|0000000491744821
|
996
|
|
|
‡2
ISNI|0000000504624950
|
996
|
|
|
‡2
ISNI|000000047382262X
|
996
|
|
|
‡2
BNF|16653712
|
996
|
|
|
‡2
SUDOC|274431602
|
996
|
|
|
‡2
ISNI|0000000493949273
|
996
|
|
|
‡2
LC|n 2016000675
|
996
|
|
|
‡2
ISNI|0000000464752404
|
996
|
|
|
‡2
CAOONL|ncf11489810
|
996
|
|
|
‡2
ISNI|000000048022963X
|
996
|
|
|
‡2
ISNI|0000000480230075
|
996
|
|
|
‡2
ISNI|0000000491698140
|
996
|
|
|
‡2
ISNI|0000000459327761
|
996
|
|
|
‡2
ISNI|0000000480229912
|
996
|
|
|
‡2
ISNI|0000000505539563
|
996
|
|
|
‡2
DNB|123593277X
|
996
|
|
|
‡2
ISNI|0000000468139877
|
996
|
|
|
‡2
PLWABN|9812373413305606
|
996
|
|
|
‡2
ISNI|0000000468704186
|
996
|
|
|
‡2
RERO|A011526764
|
996
|
|
|
‡2
ISNI|0000000512321810
|
996
|
|
|
‡2
ISNI|0000000464844042
|
996
|
|
|
‡2
ISNI|0000000491636214
|
996
|
|
|
‡2
LC|nb2014007592
|
996
|
|
|
‡2
ISNI|0000000516722822
|
996
|
|
|
‡2
ISNI|000000049286477X
|
996
|
|
|
‡2
ISNI|0000000472461383
|
996
|
|
|
‡2
ISNI|0000000492490296
|
996
|
|
|
‡2
ISNI|000000049321594X
|
996
|
|
|
‡2
LC|n 2019070074
|
996
|
|
|
‡2
ISNI|0000000467091170
|
996
|
|
|
‡2
BNF|14572353
|
996
|
|
|
‡2
ISNI|000000045984673X
|
996
|
|
|
‡2
ISNI|0000000492867217
|
996
|
|
|
‡2
ISNI|0000000505696817
|
996
|
|
|
‡2
ISNI|0000000463575661
|
996
|
|
|
‡2
ISNI|0000000480197498
|
996
|
|
|
‡2
ISNI|0000000492025466
|
996
|
|
|
‡2
ISNI|0000000505301408
|
996
|
|
|
‡2
ISNI|0000000492488209
|
996
|
|
|
‡2
LC|no2014038961
|
996
|
|
|
‡2
NII|DA02537365
|
996
|
|
|
‡2
ISNI|0000000493142170
|
996
|
|
|
‡2
ISNI|0000000505416950
|
996
|
|
|
‡2
ISNI|0000000477113003
|
996
|
|
|
‡2
ISNI|0000000505554245
|
996
|
|
|
‡2
ISNI|0000000492867196
|
996
|
|
|
‡2
ISNI|0000000467805276
|
996
|
|
|
‡2
ISNI|0000000475280895
|
996
|
|
|
‡2
ISNI|000000045940072X
|
996
|
|
|
‡2
ISNI|0000000467736856
|
996
|
|
|
‡2
ISNI|000000046803133X
|
996
|
|
|
‡2
ISNI|0000000480197519
|
996
|
|
|
‡2
NII|DA18016725
|
996
|
|
|
‡2
ISNI|0000000464407205
|
996
|
|
|
‡2
NTA|274756714
|
996
|
|
|
‡2
SZ|1080150579
|
996
|
|
|
‡2
ISNI|0000000474004821
|
996
|
|
|
‡2
BNF|16110513
|
996
|
|
|
‡2
ISNI|0000000513810958
|
996
|
|
|
‡2
ISNI|0000000473940917
|
996
|
|
|
‡2
ISNI|0000000477156935
|
996
|
|
|
‡2
DNB|1161891323
|
996
|
|
|
‡2
ISNI|0000000476979825
|
996
|
|
|
‡2
ISNI|0000000467895179
|
996
|
|
|
‡2
ISNI|0000000465109648
|
996
|
|
|
‡2
DNB|134161009
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|